Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with target-ed drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG)

被引：0
|
作者：
Boccellato, Elia
Giza, Adam
Robrecht, Sandra
Cramer, Paula
von Tresckow, Julia
Al-Sawaf, Othman
Furstenau, Moritz
Tausch, Eugen
Stilgenbauer, Stephan
Fischer, Kirsten
Eichhorst, Barbara
Vitale, Candida
Coscia, Marta
Hallek, Michael
Langerbeins, Petra
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1548000
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [31] Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs
    Vitale, Candida
    Salvetti, Chiara
    Griggio, Valentina
    Scamuffa, Maria Cristina
    Zamprogna, Giulia
    Visentin, Andrea
    Cassin, Ramona
    Laurenti, Luca
    Murru, Roberta
    Rivela, Paolo
    Marchetti, Monia
    Gentile, Massimo
    Pennese, Elsa
    Reda, Gianluigi
    Trentin, Livio
    Tedeschi, Alessandra
    Mauro, Francesca Romana
    Foa, Robin
    Boccadoro, Mario
    Coscia, Marta
    BLOOD, 2019, 134
  • [32] Prognostic factors predicting disease progression in early (Binet stage A) chronic lymphocytic leukemia (CLL):: First analysis of the CLL1-protocol of the German CLL Study Group (GCLLSG).
    Schmitt, B
    Busch, R
    Kuhn-Hallek, I
    Bergmann, M
    Wendtner, CM
    Nerl, C
    Bosse, D
    Jäger, U
    Eckart, M
    Sezer, O
    Schmid, P
    Wilhelm, M
    Blau, I
    Döhner, H
    Hiddemann, W
    Emmerich, B
    Hallek, M
    BLOOD, 2000, 96 (11) : 371A - 371A
  • [33] Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Center
    Hampel, Paul J.
    Larson, Melissa C.
    Kabat, Brian
    Call, Timothy G.
    Ding, Wei
    Kenderian, Saad Sirop
    Conte, Michael
    Schwager, Susan Marie
    Leis, Jose F.
    Chanan-Khan, Asher A.
    Slager, Susan L.
    Kay, Neil E.
    Chaffee, Kari G.
    Shanafelt, Tait D.
    Parikh, Sameer A.
    BLOOD, 2017, 130
  • [34] Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry
    Kutsch, Nadine
    Giza, Adam
    Robrecht, Sandra
    Stumpf, Janina
    Federhen, Anno
    Stoltefuss, Andrea
    Vehling-Kaiser, Ursula
    Koenigsmann, Michael
    Tausch, Eugen
    Schneider, Christof
    Stilgenbauer, Stephan
    Illmer, Thomas
    Schlag, Rudolf
    Doerfel, Steffen
    Gaska, Tobias
    Kiehl, Michael
    Mueller-Hagen, Sigrun
    Moorahrend, Enno
    Linde, Hartmut
    Schlenska-Lange, Anke
    von Tresckow, Julia
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    Fink, Anna Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (02) : 235 - 241
  • [35] Chemoimmunotherapies prolong overall survival in patients with chronic lymphocytic leukemia irrespective of time point of administration - results of a metaanalysis of the German CLL Study Group (GCLLSG)
    Isfort, S. T.
    Cramer, P.
    Bahlo, J.
    Busch, R.
    Fink, A. -M
    Langerbeins, P.
    Goede, V
    Elter, T.
    Bergmann, M.
    Stauch, M.
    Stilgenbauer, S.
    Wendtner, C.
    Eichhorst, B.
    Fischer, K.
    Hallek, M.
    ONKOLOGIE, 2012, 35 : 99 - 99
  • [36] CHARACTERISTICS, TREATMENT, AND OUTCOMES OF ≥80 YEAR OLD PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ENROLLED TO PROSPECTIVE TRIALS OF THE GERMAN CLL STUDY GROUP
    Al-Sawaf, O.
    Bahlo, J.
    Fischer, K.
    Herling, C.
    Hoechstetter, M.
    Fink, A.
    von Tresckow, J.
    Langerbeins, P.
    Cramer, P.
    Stilgenbauer, S.
    Wendtner, C.
    Eichhorst, B.
    Hallek, M.
    Goede, V.
    HAEMATOLOGICA, 2017, 102 : 421 - 421
  • [37] Characteristics, treatment, and outcomes of ≥80 year old patients with chronic lymphocytic leukemia (CLL) enrolled to prospective trials of the German CLL study group
    Al-Sawaf, O.
    Bahlo, J.
    Fischer, K.
    Herling, C.
    M., Hochstaetter
    Fink, A. M.
    von Tresckow, J.
    Langerbeins, P.
    Cramer, P.
    Stilgenbauer, S.
    Wendtner, C. M.
    Eichhorst, B.
    Hallek, M.
    Goede, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 139 - 139
  • [38] Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)
    Cramer, Paula
    Isfort, Susanne
    Bahlo, Jasmin
    Stilgenbauer, Stephan
    Doehner, Hartmut
    Bergmann, Manuela
    Stauch, Martina
    Kneba, Michael
    Lange, Elisabeth
    Langerbeins, Petra
    Pflug, Natali
    Kovacs, Gabor
    Goede, Valentin
    Fink, Anna-Maria
    Elter, Thomas
    Fischer, Kirsten
    Wendtner, Clemens-Martin
    Hallek, Michael
    Eichhorst, Barbara
    HAEMATOLOGICA, 2015, 100 (11) : 1451 - 1459
  • [39] The Performance of Computed Tomography (CT) Scans or Ultrasound Has No Clinical Relevance in Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Metaanalysis from Three Phase III Studies of the German CLL Study Group (GCLLSG).
    Eichhorst, Barbara F.
    Fischer, Kirsten
    Fink, Anna-Maria
    Elter, Thomas
    Wendtner, Clemens M.
    Busch, Raymonde
    Hallek, Michael
    BLOOD, 2008, 112 (11) : 385 - 386
  • [40] Mode of progression correlates with further clinical outcome of chronic lymphocytic leukemia (CLL). A meta-analysis by the German CLL study group
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    von Tresckow, J.
    Cramer, P.
    Langerbeins, P.
    Kutsch, N.
    Wendtner, C. M.
    Fischer, K.
    Eichhorst, B.
    Goede, V.
    Hallek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 138 - 138
12345